Celltrion, Stock Price +1.89% at This Time... Foreigners Net Buy 220,914 Shares in Last 5 Days

As of 2:30 PM on the 22nd, Celltrion is trading at 297,000 KRW, up 1.89% from the previous day. The trading volume is 1,021,205 shares, which is about 95.7% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On June 17, Dalmi Lee, a researcher at SK Securities, stated, "Celltrion has acquired Takeda Primary Care's Asia-Pacific division, obtaining all rights to 12 original prescription drug brands and 6 over-the-counter drug brands. This acquisition is expected to propel Celltrion into a global comprehensive pharmaceutical company. The continued strong performance growth through the second half of the year, the ban on short selling, and the development of COVID-19 treatments are expected to act as positive momentum for stock price increases in the latter half of the year." The target price for Celltrion was set at 370,000 KRW.

Over the past five days, individual investors have net sold 68,201 shares of Celltrion, while foreign investors and institutions have net bought 220,914 shares and net sold 154,085 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.